To date, only 2 drug-eluting stents have been approved for commercial use: the Cypher sirolimus-eluting stent (Cordis Corp.; Miami, Florida) and the Taxus paclitaxel-eluting stent (Boston ...

Atlanta, GA - Thirty-day and 6-month results from the TAXUS III study indicate that paclitaxel (Taxol® - Bristol-Myers Squibb)-coated stents hold promise for treating in-stent restenosis ...